- Home
- NVO vs HSBC Comparison
NVO vs HSBC Comparison
Compare NVO & HSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVO | HSBC |
|---|---|---|
| Founded | 1923 | 1865 |
| Country | Denmark | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.6B | 226.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NVO | HSBC |
|---|---|---|
| Price | $62.29 | $83.71 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $54.25 | N/A |
| AVG Volume (30 Days) | ★ 22.8M | 1.5M |
| Earning Date | 02-04-2026 | 02-18-2026 |
| Dividend Yield | 2.08% | ★ 3.94% |
| EPS Growth | ★ 10.06 | N/A |
| EPS | ★ 3.67 | 0.93 |
| Revenue | $49,580,393,058.00 | ★ $57,976,000,000.00 |
| Revenue This Year | $7.25 | $13.11 |
| Revenue Next Year | $0.24 | $1.87 |
| P/E Ratio | ★ $16.18 | $89.48 |
| Revenue Growth | ★ 16.64 | 0.01 |
| 52 Week Low | $43.08 | $45.66 |
| 52 Week High | $93.80 | $83.35 |
Technical Indicators
Market Signals| Indicator | NVO | HSBC |
|---|---|---|
| Relative Strength Index (RSI) | 67.72 | 73.22 |
| Support Level | $57.56 | $81.94 |
| Resistance Level | $62.40 | $83.05 |
| Average True Range (ATR) | 1.75 | 0.76 |
| MACD | 0.39 | -0.02 |
| Stochastic Oscillator | 98.59 | 87.70 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About HSBC HSBC Holdings plc.
Established in 1865 in Hong Kong, London-based HSBC is one of the largest banks in the world, with assets of USD 3 trillion and 40 million customers worldwide. It operates in more than 50 countries with more than 200,000 full-time staff. The United Kingdom and Hong Kong are its two largest markets. The bank offers retail, commercial and institutional banking, global banking and markets, wealth management, and private banking.